메뉴 건너뛰기




Volumn 24, Issue 6, 2012, Pages 680-681

Intensive luteal-phase support with oestradiol and progesterone after GnRH-agonist triggering: Does it help?

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; ESTRADIOL VALERATE; ESTROFEM; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT LUTEINIZING HORMONE;

EID: 84861816819     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2012.03.005     Document Type: Letter
Times cited : (20)

References (6)
  • 1
    • 38049170879 scopus 로고    scopus 로고
    • The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: A prospective randomised controlled study
    • L. Engmann, A. DiLuigi, D. Schmidt, J. Nulsen, D. Maier, and C. Benadiva The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomised controlled study Fertil. Steril. 89 2008 84 91
    • (2008) Fertil. Steril. , vol.89 , pp. 84-91
    • Engmann, L.1    Diluigi, A.2    Schmidt, D.3    Nulsen, J.4    Maier, D.5    Benadiva, C.6
  • 2
    • 75749138165 scopus 로고    scopus 로고
    • 1500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin- releasing hormone agonist is used for ovulation induction: A prospective, randomized, controlled study
    • P. Humaidan, H.E. Bredkjaer, L.G. Westergaard, and C.Y. Andersen 1500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin- releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study Fertil. Steril. 93 2010 847 854
    • (2010) Fertil. Steril. , vol.93 , pp. 847-854
    • Humaidan, P.1    Bredkjaer, H.E.2    Westergaard, L.G.3    Andersen, C.Y.4
  • 4
    • 14044276987 scopus 로고    scopus 로고
    • Can we eliminate ovarian hyperstimulation syndrome?
    • R. Orvieto Can we eliminate ovarian hyperstimulation syndrome? Hum. Reprod. 20 2005 320 322
    • (2005) Hum. Reprod. , vol.20 , pp. 320-322
    • Orvieto, R.1
  • 5
    • 33747065541 scopus 로고    scopus 로고
    • Substituting HCG with GnRH agonist to trigger final follicular maturation - A retrospective comparison of three different ovarian stimulation protocols
    • R. Orvieto, J. Rabinson, S. Meltzer, E. Zohav, E. Anteby, and R. Homburg Substituting HCG with GnRH agonist to trigger final follicular maturation-a retrospective comparison of three different ovarian stimulation protocols Reprod. Biomed. Online 13 2006 198 201
    • (2006) Reprod. Biomed. Online , vol.13 , pp. 198-201
    • Orvieto, R.1    Rabinson, J.2    Meltzer, S.3    Zohav, E.4    Anteby, E.5    Homburg, R.6
  • 6
    • 79951945981 scopus 로고    scopus 로고
    • A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: A randomized prospective proof of concept study
    • E.G. Papanikolaou, W. Verpoest, H. Fatemi, B. Tarlatzis, P. Devroey, and H. Tournaye A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study Fertil. Steril. 95 2011 1174 1177
    • (2011) Fertil. Steril. , vol.95 , pp. 1174-1177
    • Papanikolaou, E.G.1    Verpoest, W.2    Fatemi, H.3    Tarlatzis, B.4    Devroey, P.5    Tournaye, H.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.